These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21529940)

  • 1. Flow cytometry in myelodysplastic syndromes: ready for translation into clinical practice.
    van de Loosdrecht AA; Westers TM
    Leuk Res; 2011 Jul; 35(7):850-2. PubMed ID: 21529940
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow cytometry will be a routine tool in clinical practice in myelodysplastic syndromes: a real story.
    Ogata K
    Leuk Res; 2011 Jul; 35(7):848-9. PubMed ID: 21466893
    [No Abstract]   [Full Text] [Related]  

  • 3. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes.
    Chu SC; Wang TF; Li CC; Kao RH; Li DK; Su YC; Wells DA; Loken MR
    Leuk Res; 2011 Jul; 35(7):868-73. PubMed ID: 21397943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: ready for prime time?
    Hasserjian RP; Preffer FI
    Leuk Res; 2012 Sep; 36(9):1089-90. PubMed ID: 22727507
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.
    Alhan C; Westers TM; Cremers EM; Cali C; Ossenkoppele GJ; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2016 Jul; 90(4):358-67. PubMed ID: 26517178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes.
    Duetz C; Westers TM; van de Loosdrecht AA
    Pathobiology; 2019; 86(1):14-23. PubMed ID: 30227408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group.
    van de Loosdrecht AA; Ireland R; Kern W; Della Porta MG; Alhan C; Balleisen JS; Bettelheim P; Bowen DT; Burbury K; Eidenschink L; Cazzola M; Chu SS; Cullen M; Cutler JA; Dräger AM; Feuillard J; Fenaux P; Font P; Germing U; Haase D; Hellström-Lindberg E; Johansson U; Kordasti S; Loken MR; Malcovati L; te Marvelde JG; Matarraz S; Milne T; Moshaver B; Mufti GJ; Nikolova V; Ogata K; Oelschlaegel U; Orfao A; Ossenkoppele GJ; Porwit A; Platzbecker U; Preijers F; Psarra K; Richards SJ; Subirá D; Seymour JF; Tindell V; Vallespi T; Valent P; van der Velden VH; Wells DA; de Witte TM; Zettl F; Béné MC; Westers TM
    Leuk Lymphoma; 2013 Mar; 54(3):472-5. PubMed ID: 22916713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometry in myelodysplastic syndromes: report from a working conference.
    Loken MR; van de Loosdrecht A; Ogata K; Orfao A; Wells DA
    Leuk Res; 2008 Jan; 32(1):5-17. PubMed ID: 17576013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.
    Cazzola M
    Haematologica; 2009 Aug; 94(8):1041-3. PubMed ID: 19644135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplastic syndromes: the role of flow cytometry in diagnosis and prognosis.
    Stetler-Stevenson M; Yuan CM
    Int J Lab Hematol; 2009 Oct; 31(5):479-83. PubMed ID: 19555363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of flow cytometry in the diagnostic work-up of myelodysplastic syndromes in a multicenter approach: report from the Dutch Working Party on Flow Cytometry in MDS.
    Westers TM; van der Velden VH; Alhan C; Bekkema R; Bijkerk A; Brooimans RA; Cali C; Dräger AM; de Haas V; Homburg C; de Jong A; Kuiper-Kramer PE; Leenders M; Lommerse I; te Marvelde JG; van der Molen-Sinke JK; Moshaver B; Mulder AB; Preijers FW; Schindhelm RK; van der Sluijs A; van Wering ER; Westra AH; van de Loosdrecht AA;
    Leuk Res; 2012 Apr; 36(4):422-30. PubMed ID: 21982641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is There a Role for Flow Cytometry in the Evaluation of Patients With Myelodysplastic Syndromes?
    Porwit A
    Curr Hematol Malig Rep; 2015 Sep; 10(3):309-17. PubMed ID: 26122389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients.
    Kern W; Bacher U; Haferlach C; Alpermann T; Schnittger S; Haferlach T
    Cytometry B Clin Cytom; 2015; 88(3):154-64. PubMed ID: 25581461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research in morphology and flow cytometry is at the heart of hematology.
    Béné MC; Zini G;
    Haematologica; 2017 Mar; 102(3):421-422. PubMed ID: 28250005
    [No Abstract]   [Full Text] [Related]  

  • 15. A multiparametric flow cytometry immunophenotypic scoring system for the diagnosis and prognosis of myelodysplastic syndromes.
    Huang J; Lai P; Zhou M; Weng J; Lu Z; Du X
    Clin Lab; 2012; 58(11-12):1241-51. PubMed ID: 23289195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of flow cytometric immunophenotyping in diagnosis of myelodysplastic syndromes--review].
    Zhang Y; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1477-81. PubMed ID: 19099668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes.
    Cremers EM; Westers TM; Alhan C; Cali C; Visser-Wisselaar HA; Chitu DA; van der Velden VH; Te Marvelde JG; Klein SK; Muus P; Vellenga E; de Greef GE; Legdeur MC; Wijermans PW; Stevens-Kroef MJ; Silva-Coelho PD; Jansen JH; Ossenkoppele GJ; van de Loosdrecht AA;
    Haematologica; 2017 Feb; 102(2):320-326. PubMed ID: 27658438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On flow cytometry in myelodysplastic syndromes, with caveats.
    Wells DA; Ogata K
    Leuk Res; 2008 Feb; 32(2):209-10. PubMed ID: 17825408
    [No Abstract]   [Full Text] [Related]  

  • 19. Flowcytometry in myelodysplastic syndromes: towards a new paradigm in diagnosis and prognostication?
    van de Loosdrecht AA; Westers TM; Ossenkoppele GJ
    Leuk Res; 2008 Feb; 32(2):205-7. PubMed ID: 17714781
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical applications of molecular haematology: flow cytometry in leukaemias and myelodysplastic syndromes.
    Dalal BI
    J Assoc Physicians India; 2007 Aug; 55():571-3. PubMed ID: 18019799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.